Halda Therapeutics has struck a deal with VantAI, entering into a pact that could be worth more than $1 billion to secure a source of targets for its novel approach to oncology and immunology. Yale ...
Johnson & Johnson plans to acquire clinical-stage biotech Halda Therapeutics OpCo. Inc. in a deal worth $3.05 billion. The New Brunswick-based pharma giant announced the agreement Nov. 17. The move ...
Over the past two calendar years, acquirers have agreed to pay more than $38 billion to purchase venture-backed companies in ...
Johnson & Johnson is adding to its oncology pipeline with a $3.05 billion deal to acquire Halda Therapeutics, a startup whose first-in-class approach to prostate cancer could overcome drug resistance ...
Johnson & Johnson (J&J) has signed a definitive agreement for the acquisition of Halda Therapeutics (Halda) in a $3.05bn cash deal. The acquisition brings Halda's lead candidate, HLD-0915, a ...
Johnson & Johnson finalized its $3.05 billion acquisition of clinical-stage biotech Halda Therapeutics OpCo. Inc. In a Dec. 29 press release announcing the closing, the New Brunswick-based ...
NEW YORK & NEW HAVEN, Conn.--(BUSINESS WIRE)--VantAI, the leader in generative AI for proximity drug discovery, and Halda Therapeutics, the pioneer of RIPTAC (Regulated Induced Proximity Targeting ...
Johnson & Johnson on Monday announced a $3.1 billion deal to buy privately-held cancer biotech Halda Therapeutics, the latest in a cavalcade of biotech acquisitions as the sector has heated up over ...
Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while strengthening its prostate cancer franchise built on Erleada. At the center of the ...
Halda Therapeutics, a startup developing new cancer-fighting technology, has raised $126 million in new funding to advance experimental drugs into human testing for prostate and breast cancers, the ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Halda Therapeutics, a clinical-stage biotechnology company developing a novel class of cancer therapies called RIPTAC™ (Regulated Induced Proximity TArgeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results